Europe Clot Busting Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Product, By Route of Administration, By Indication, By Country and Growth Forecast, 2023

List of Tables

The Europe Clot Busting Drugs Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030).

Plans for treatment and the optimum usage of clot-buster therapy can be created using genetic testing, biomarker analysis, and the unique characteristics of each patient. Targeted therapies are made possible by personalized medicine approaches, improving treatment outcomes and patient satisfaction. Therefore, stroke is a severe public health issue with significant economic and social repercussions. These are the main variables anticipated to generate growth possibilities for market participants during the projected period.

Clot busting drugs can help by dissolving blood clots collecting in the veins, which lowers blood pressure, and can help with the increased incidence of strokes. The market is growing due to strokes expanding the population's mortality rate. Additionally, it is predicted that the market will grow throughout the projection period due to the rising risk of ischemic stroke in the population. A considerable death rate is associated with stroke and significant morbidity, which leaves up to 50% of survivors with a long-term disability. As a result, stroke is a disorder crucial to public health and significantly negatively affects the economy and society.

In the UK, combating obesity is one of the nation's major long-term health issues. Nowadays, over two-thirds (63%) of people are overweight, and approximately half are obese. One-third of children leaving primary school are overweight or obese, and one-fifth of youngsters are obese. The high prevalence of obesity and its associated health issues are anticipated to increase the risk of health conditions such as CVD and others. As a result, the rising obesity across the regional nations further raise the need for the clot busting drugs, hence supporting the regional market expansion.

The Germany market dominated the Europe Clot Busting Drugs Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3.1 billion by 2030. The UK market is poised to grow at a CAGR of 6.8% during (2023 - 2030). Additionally, The France market would witness a CAGR of 8.5% during (2023 - 2030).

Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on Product, the market is segmented into Anticoagulants, Thrombolytic Drugs, Anti-Platelet Drugs and Others. Based on Route of Administration, the market is segmented into Injectable and Oral. Based on Indication, the market is segmented into Pulmonary Embolism, Atrial Fibrillation, Deep Vein Thrombosis and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Dr. Reddy's Laboratories Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Bristol Myers Squibb Company, Eli Lilly And Company, Johnson & Johnson (Johnson & Johnson Services, Inc.), Pfizer, Inc., Merck & Co., Inc.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Product

Anticoagulants
Thrombolytic Drugs
Anti-Platelet Drugs
Others

By Route of Administration

Injectable
Oral

By Indication

Pulmonary Embolism
Atrial Fibrillation
Deep Vein Thrombosis
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

Sanofi S.A.
Dr. Reddy's Laboratories Ltd.
Bayer AG
Boehringer Ingelheim International GmbH
Sun Pharmaceutical Industries Ltd.
Bristol Myers Squibb Company
Eli Lilly And Company
Johnson & Johnson (Johnson & Johnson Services, Inc.)
Pfizer, Inc.
Merck & Co., Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Clot Busting Drugs Market, by Distribution Channel
- 1.4.2 Europe Clot Busting Drugs Market, by Product
- 1.4.3 Europe Clot Busting Drugs Market, by Route of Administration
- 1.4.4 Europe Clot Busting Drugs Market, by Indication
- 1.4.5 Europe Clot Busting Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Forces Analysis

Chapter 4. Europe Clot Busting Drugs Market by Distribution Channel

4.1 Europe Hospital Pharmacy Market by Country
4.2 Europe Retail Pharmacy Market by Country
4.3 Europe Online Pharmacy Market by Country

Chapter 5. Europe Clot Busting Drugs Market by Product

5.1 Europe Anticoagulants Market by Country
5.2 Europe Thrombolytic Drugs Market by Country
5.3 Europe Anti-Platelet Drugs Market by Country
5.4 Europe Others Market by Country

Chapter 6. Europe Clot Busting Drugs Market by Route of Administration

6.1 Europe Injectable Market by Country
6.2 Europe Oral Market by Country

Chapter 7. Europe Clot Busting Drugs Market by Indication

7.1 Europe Pulmonary Embolism Market by Country
7.2 Europe Atrial Fibrillation Market by Country
7.3 Europe Deep Vein Thrombosis Market by Country
7.4 Europe Others Market by Country

Chapter 8. Europe Clot Busting Drugs Market by Country

8.1 Germany Clot Busting Drugs Market
- 8.1.1 Germany Clot Busting Drugs Market by Distribution Channel
- 8.1.2 Germany Clot Busting Drugs Market by Product
- 8.1.3 Germany Clot Busting Drugs Market by Route of Administration
- 8.1.4 Germany Clot Busting Drugs Market by Indication
8.2 UK Clot Busting Drugs Market
- 8.2.1 UK Clot Busting Drugs Market by Distribution Channel
- 8.2.2 UK Clot Busting Drugs Market by Product
- 8.2.3 UK Clot Busting Drugs Market by Route of Administration
- 8.2.4 UK Clot Busting Drugs Market by Indication
8.3 France Clot Busting Drugs Market
- 8.3.1 France Clot Busting Drugs Market by Distribution Channel
- 8.3.2 France Clot Busting Drugs Market by Product
- 8.3.3 France Clot Busting Drugs Market by Route of Administration
- 8.3.4 France Clot Busting Drugs Market by Indication
8.4 Russia Clot Busting Drugs Market
- 8.4.1 Russia Clot Busting Drugs Market by Distribution Channel
- 8.4.2 Russia Clot Busting Drugs Market by Product
- 8.4.3 Russia Clot Busting Drugs Market by Route of Administration
- 8.4.4 Russia Clot Busting Drugs Market by Indication
8.5 Spain Clot Busting Drugs Market
- 8.5.1 Spain Clot Busting Drugs Market by Distribution Channel
- 8.5.2 Spain Clot Busting Drugs Market by Product
- 8.5.3 Spain Clot Busting Drugs Market by Route of Administration
- 8.5.4 Spain Clot Busting Drugs Market by Indication
8.6 Italy Clot Busting Drugs Market
- 8.6.1 Italy Clot Busting Drugs Market by Distribution Channel
- 8.6.2 Italy Clot Busting Drugs Market by Product
- 8.6.3 Italy Clot Busting Drugs Market by Route of Administration
- 8.6.4 Italy Clot Busting Drugs Market by Indication
8.7 Rest of Europe Clot Busting Drugs Market
- 8.7.1 Rest of Europe Clot Busting Drugs Market by Distribution Channel
- 8.7.2 Rest of Europe Clot Busting Drugs Market by Product
- 8.7.3 Rest of Europe Clot Busting Drugs Market by Route of Administration
- 8.7.4 Rest of Europe Clot Busting Drugs Market by Indication

Chapter 9. Company Profiles

9.1 Sanofi S.A.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Trials and Approvals:
- 9.1.6 SWOT Analysis
9.2 Dr. Reddy's Laboratories Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 SWOT Analysis
9.3 Bayer AG
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
9.4 Boehringer Ingelheim International Gmbh
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Regional & Segmental Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
  - 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
9.5 Sun Pharmaceutical Industries Ltd.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 SWOT Analysis
9.6 Bristol Myers Squibb Company
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.6 SWOT Analysis
9.7 Eli Lilly And Company
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Johnson & Johnson (Johnson & Johnson Services, Inc.)
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental &Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 SWOT Analysis
9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 SWOT Analysis
- 9.9.4 Regional & Segmental Analysis
- 9.9.5 Research & Development Expense
- 9.9.6 SWOT Analysis
9.10. Merck & Co., Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 Europe Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 2 Europe Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 3 Europe Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 Europe Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 12 Europe Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 13 Europe Anticoagulants Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Anticoagulants Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Thrombolytic Drugs Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Thrombolytic Drugs Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Anti-Platelet Drugs Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Anti-Platelet Drugs Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 22 Europe Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 23 Europe Injectable Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Injectable Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Oral Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Oral Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 28 Europe Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 29 Europe Pulmonary Embolism Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Pulmonary Embolism Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Atrial Fibrillation Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Atrial Fibrillation Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Deep Vein Thrombosis Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Deep Vein Thrombosis Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 36 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 37 Europe Clot Busting Drugs Market by Country, 2019 - 2022, USD Million
TABLE 38 Europe Clot Busting Drugs Market by Country, 2023 - 2030, USD Million
TABLE 39 Germany Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 40 Germany Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 41 Germany Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Germany Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 Germany Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 44 Germany Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 45 Germany Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 46 Germany Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 47 Germany Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 48 Germany Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 49 UK Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 50 UK Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 51 UK Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 UK Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 53 UK Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 54 UK Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 55 UK Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 UK Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 57 UK Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 58 UK Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 59 France Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 60 France Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 61 France Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 France Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 63 France Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 64 France Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 65 France Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 66 France Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 67 France Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 68 France Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 69 Russia Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 70 Russia Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 71 Russia Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 72 Russia Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 73 Russia Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 74 Russia Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 75 Russia Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 76 Russia Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 77 Russia Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 78 Russia Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 79 Spain Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 80 Spain Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 81 Spain Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Spain Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 83 Spain Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 84 Spain Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 85 Spain Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 86 Spain Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 87 Spain Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 88 Spain Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 89 Italy Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 90 Italy Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 91 Italy Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 92 Italy Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 93 Italy Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 94 Italy Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 95 Italy Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 96 Italy Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 97 Italy Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 98 Italy Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 99 Rest of Europe Clot Busting Drugs Market, 2019 - 2022, USD Million
TABLE 100 Rest of Europe Clot Busting Drugs Market, 2023 - 2030, USD Million
TABLE 101 Rest of Europe Clot Busting Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 102 Rest of Europe Clot Busting Drugs Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 103 Rest of Europe Clot Busting Drugs Market by Product, 2019 - 2022, USD Million
TABLE 104 Rest of Europe Clot Busting Drugs Market by Product, 2023 - 2030, USD Million
TABLE 105 Rest of Europe Clot Busting Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 106 Rest of Europe Clot Busting Drugs Market by Route of Administration, 2023 - 2030, USD Million
TABLE 107 Rest of Europe Clot Busting Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 108 Rest of Europe Clot Busting Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 109 Key Information - Sanofi S.A.
TABLE 110 Key Information - Dr. Reddy's Laboratories Ltd.
TABLE 111 Key Information - Bayer AG
TABLE 112 Key Information - Boehringer Ingelheim International GmbH
TABLE 113 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 114 Key Information - Bristol Myers Squibb Company
TABLE 115 Key Information - Eli Lilly And Company
TABLE 116 Key Information - Johnson & Johnson
TABLE 117 Key Information - Pfizer, Inc.
TABLE 118 Key Information - Merck & Co., Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 Europe Clot Busting Drugs Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Clot Busting Drugs Market
FIG 4 Porter's Five Forces Analysis - Clot Busting Drugs Market
FIG 5 Europe Clot Busting Drugs Market share by Distribution Channel, 2022
FIG 6 Europe Clot Busting Drugs Market share by Distribution Channel, 2030
FIG 7 Europe Clot Busting Drugs Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 Europe Clot Busting Drugs Market share by Product, 2022
FIG 9 Europe Clot Busting Drugs Market share by Product, 2030
FIG 10 Europe Clot Busting Drugs Market by Product, 2019 - 2030, USD Million
FIG 11 Europe Clot Busting Drugs Market share by Route of Administration, 2022
FIG 12 Europe Clot Busting Drugs Market share by Route of Administration, 2030
FIG 13 Europe Clot Busting Drugs Market by Route of Administration, 2019 - 2030, USD Million
FIG 14 Europe Clot Busting Drugs Market share by Indication, 2022
FIG 15 Europe Clot Busting Drugs Market share by Indication, 2030
FIG 16 Europe Clot Busting Drugs Market by Indication, 2019 - 2030, USD Million
FIG 17 Europe Clot Busting Drugs Market share by Country, 2022
FIG 18 Europe Clot Busting Drugs Market share by Country, 2030
FIG 19 Europe Clot Busting Drugs Market by Country, 2019 - 2030, USD Million
FIG 20 Swot Analysis: Sanofi S.A.
FIG 21 Swot Analysis: Dr. Reddy's Laboratories Ltd.
FIG 22 Swot Analysis: Bayer AG
FIG 23 Swot Analysis: Boehringer Ingelheim International GmbH
FIG 24 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
FIG 25 SWOT Analysis: Bristol Myers Squibb Company
FIG 26 Swot Analysis: Eli Lilly And Company
FIG 27 Swot Analysis: Johnson & Johnson
FIG 28 Swot Analysis: Pfizer, Inc.
FIG 29 Swot Analysis: Pfizer, Inc.
FIG 30 Swot Analysis: Merck & Co., Inc.

Europe Clot Busting Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Product, By Route of Administration, By Indication, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents